Search - tctmd.com

Displaying 381 - 400 of 698

Sort: Relevancy | Date

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

News Conference News EuroPCR 2017

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Caitlin E. Cox

May 18, 2017

Podcast

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

May 17, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Daily News

Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR

Shelley Wood

April 24, 2017

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

News Industry News

Eurocor announces the completion of the Freeway Stent Study

April 04, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

News Daily News

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

L.A. McKeown

March 02, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

Rate of Incomplete Revascularization During PCI Is Highly Variable Across Operators

Todd Neale

February 15, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

News Industry News

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

February 09, 2017

Presentation JIM 2017

The EluNIR clinical program: BIONICS and NIREUS - One Year Follow Up

Presenter: Giuseppe Musumeci

February 09, 2017

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

Advertisement

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

The Left Main Debate: What Does it Mean for the Future of Intervention?

Eurocor announces the completion of the Freeway Stent Study

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Rate of Incomplete Revascularization During PCI Is Highly Variable Across Operators

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

First Drug-Coated Balloon (DCB) Study Results in Japan Demonstrate Consistent Clinical Outcomes with Other Medtronic DCB Studies

The EluNIR clinical program: BIONICS and NIREUS - One Year Follow Up

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content